Insilico Medicine Posts First Profit, $106.3M Revenue in First Half of 2026
This story is from 2026-08-26. It is preserved in the archive; the latest stories are on the live feed.
The clinical-stage generative AI drug discovery company recorded a net profit of $35.54 million and an adjusted net profit of $51.23 million, with positive operating cash flow, in its first interim report since listing on the Hong Kong Stock Exchange at the end of 2025. The results, released August…
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-08-26 11:00 · Unite.AI
Insilico Medicine Posts First Profit, $106.3M Revenue in First Half of 2026